nach oben

High Blood Pressure & Cardiovascular Prevention

Erschienen in:

03.02.2024 | Original article

Acute Effects of Coffee Consumption on Blood Pressure and Endothelial Function in Individuals with Hypertension on Antihypertensive Drug Treatment: A Randomized Crossover Trial

verfasst von: Fernanda Barboza de Araujo Lima de Castro, Flávia Garcia Castro, Michelle Rabello da Cunha, Sidney Pacheco, Otniel Freitas-Silva, Mario Fritsch Neves, Marcia Regina Simas Torres Klein

Erschienen in: High Blood Pressure & Cardiovascular Prevention | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Coffee is a complex brew that contains several bioactive compounds and some of them can influence blood pressure (BP) and endothelial function (EF), such as caffeine and chlorogenic acids (CGAs).

Aim

This study aimed to evaluate the acute effects of coffee on BP and EF in individuals with hypertension on drug treatment who were habitual coffee consumers.

Methods

This randomized crossover trial assigned 16 adults with hypertension to receive three test beverages one week apart: caffeinated coffee (CC; 135 mg caffeine, 61 mg CGAs), decaffeinated coffee (DC; 5 mg caffeine, 68 mg CGAs), and water. BP was continuously evaluated from 15 min before to 90 min after test beverages by digital photoplethysmography. Reactive hyperemia index (RHI) assessed by peripheral arterial tonometry evaluated EF before and at 90 min after test beverages. At the same time points, microvascular reactivity was assessed by laser speckle contrast imaging. Repeated-measures-ANOVA evaluated the effect of time, the effect of beverage, and the interaction between time and beverage (treatment effect).

Results

Although the intake of CC produced a significant increase in BP and a significant decrease in RHI, these changes were also observed after the intake of DC and were not significantly different from the modifications observed after the consumption of DC and water. Microvascular reactivity did not present significant changes after the 3 beverages.

Conclusion

CC in comparison with DC and water neither promoted an acute increase in BP nor produced an improvement or deleterious effect on EF in individuals with hypertension on drug treatment who were coffee consumers.

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. https://doi.org/10.1038/s41581-019-0244-2.CrossRefPubMedPubMedCentral

Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911. https://doi.org/10.1016/S0140-6736(14)60685-1.CrossRefPubMedPubMedCentral

GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6.CrossRef

Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(1):28–36. https://doi.org/10.1001/jamainternmed.2017.6015.CrossRefPubMed

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. 2018 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339.CrossRefPubMed

Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK. Hypertension. Nat Rev Dis Primers. 2018;4:18014. https://doi.org/10.1038/nrdp.2018.14.CrossRefPubMedPubMedCentral

Appel LJ. The effects of dietary factors on blood pressure. Cardiol Clin. 2017;35(2):197–212. https://doi.org/10.1016/j.ccl.2016.12.002.CrossRefPubMed

Paul KW, Robert MC, Wilbert SA, Donald EC, Karen JC, Cheryl DH, Sondra MD, Samuel G, Kenneth AJ, Daniel WJ, Eric JML, Paul M, Bruce O, Sidney CS, Crystal CS, Randall SS, Sandra JT, Randal JT, Kim AW, Jeff DW, Jackson TW. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.

Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94(4):1113–26. https://doi.org/10.3945/ajcn.111.016667.CrossRefPubMed

10.

van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med. 2020;383(4):369–78. https://doi.org/10.1056/NEJMra1816604.CrossRefPubMed

11.

Chrysant SG. The impact of coffee consumption on blood pressure, cardiovascular disease and diabetes mellitus. Expert Rev Cardiovasc Ther. 2017;15(3):151–6. https://doi.org/10.1080/14779072.2017.1287563.CrossRefPubMed

12.

Reyes CM, Cornelis MC. Caffeine in the diet: country-level consumption and guidelines. Nutrients. 2018;10(11):1772. https://doi.org/10.3390/nu10111772.CrossRefPubMedPubMedCentral

13.

Sartori GO, Silva MV. Caffeine in Brazil: intake, socioeconomic and demographic determinants, and major dietary sources. Nutrire. 2016;41:11. https://doi.org/10.1186/s41110-016-0014-x.CrossRef

14.

Fulgoni VL 3rd, Keast DR, Lieberman HR. Trends in intake and sources of caffeine in the diets of US adults: 2001–2010. Am J Clin Nutr. 2015;101(5):1081–7. https://doi.org/10.3945/ajcn.113.080077.CrossRefPubMed

15.

O’Keefe JH, DiNicolantonio JJ, Lavie CJ. Coffee for cardioprotection and longevity. Prog Cardiovasc Dis. 2018;61(1):38–42. https://doi.org/10.1016/j.pcad.2018.02.002.CrossRefPubMed

16.

Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory. Food Data Central. 2022. https://fdc.nal.usda.gov/.

17.

Zhao Y, Wang J, Ballevre O, Luo H, Zhang W. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res. 2012;35(4):370–4. https://doi.org/10.1038/hr.2011.195.CrossRefPubMed

18.

Liang N, Kitts DD. Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients. 2015;8(1):16. https://doi.org/10.3390/nu8010016.CrossRefPubMedPubMedCentral

19.

Rebello SA, Van Dam RM. Coffee consumption and cardiovascular health: getting to the heart of the matter topical collection on ischemic heart disease. Curr Cardiol Rep. 2013;15(10):403. https://doi.org/10.1007/s11886-013-0403-1.CrossRefPubMed

20.

Buscemi S, Verga S, Batsis JA, Donatelli M, Tranchina MR, Belmonte S, Mattina A, Re A, Cerasola G. Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr. 2010;64(5):483–9. https://doi.org/10.1038/ejcn.2010.9.CrossRefPubMed

21.

Teng CL, Lim WY, Chua CZ, Teo RS, Lin KT, Yeo JC. Does a single cup of caffeinated drink significantly increase blood pressure in young adults? A randomised controlled trial. Aust Fam Phys. 2016;45(1):65–8.

22.

Boon EAJ, Croft KD, Shinde S, Hodgson JM, Ward NC. The acute effect of coffee on endothelial function and glucose metabolism following a glucose load in healthy human volunteers. Food Funct. 2017;8(9):3366–73. https://doi.org/10.1039/c7fo00926g.CrossRefPubMed

23.

Washio T, Sasaki H, Ogoh S. Acute impact of drinking coffee on the cerebral and systemic vasculature. Physiol Rep. 2017;5(10):e13288. https://doi.org/10.14814/phy2.13288.CrossRefPubMedPubMedCentral

24.

Mahmud A, Feely J. Acute effect of caffeine on arterial stiffness and aortic pressure waveform. Hypertension. 2001;38(2):227–31. https://doi.org/10.1161/01.hyp.38.2.227.CrossRefPubMed

25.

Karatzis E, Papaioannou TG, Aznaouridis K, Karatzi K, Stamatelopoulos K, Zampelas A, Papamichael C, Lekakis J, Mavrikakis M. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure? Int J Cardiol. 2005;98(3):425–30. https://doi.org/10.1016/j.ijcard.2003.11.013.CrossRefPubMed

26.

Noguchi K, Matsuzaki T, Sakanashi M, Hamadate N, Uchida T, Kina-Tanada M, Kubota H, Nakasone J, Sakanashi M, Ueda S, Masuzaki H, Ishiuchi S, Ohya Y, Tsutsui M. Effect of caffeine contained in a cup of coffee on microvascular function in healthy subjects. J Pharmacol Sci. 2015;127(2):217–22. https://doi.org/10.1016/j.jphs.2015.01.003.CrossRefPubMed

27.

Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, Vamvakou G, Lekakis JP, Mavrikakis ME. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond). 2005;109(1):55–60. https://doi.org/10.1042/CS20040358.CrossRefPubMed

28.

Pavão TP, Chemello D, Ferigollo A, Saffi MAL, Moresco RN, Stein CDS, Emanuelli T, Somacal S, Moriguchi EH, Badimon L, Chagas P. Acute effect of coffee on arterial stiffness and endothelial function in overweight and obese individuals: A randomized clinical trial. Clin Nutr ESPEN. 2022;50:33–40. https://doi.org/10.1016/j.clnesp.2022.05.003.CrossRefPubMed

29.

Hartley TR, Sung BH, Pincomb GA, Whitsett TL, Wilson MF, Lovallo WR. Hypertension risk status and effect of caffeine on blood pressure. Hypertension. 2000;36(1):137–41. https://doi.org/10.1161/01.hyp.36.1.137.CrossRefPubMed

30.

Turnbull D, Rodricks JV, Mariano GF, Chowdhury F. Caffeine and cardiovascular health. Regul Toxicol Pharmacol. 2017;89:165–85. https://doi.org/10.1016/j.yrtph.2017.07.025.CrossRefPubMed

31.

Izzo JL, Ghosal A, Kwong T, Freeman RB, Jaenike JR. Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am J Cardiol. 1983;52(7):769–73. https://doi.org/10.1016/0002-9149(83)90413-7.CrossRefPubMed

32.

Corrêa CLO, Merces-Penha E, Dos Anjos MR, Pacheco S, Freitas-Silva O, Luna AS, Gottschalk LMF. Use of asparaginase for acrylamide mitigation in coffee and its influence on the content of caffeine, chlorogenic acid, and caffeic acid. Food Chem. 2021;338:128045. https://doi.org/10.1016/j.foodchem.2020.128045.CrossRefPubMed

33.

Sichieri R, Everhart JE. Validity of a Brazilian frequency questionnaire against dietary recalls and estimated energy intake. Nutr Res. 1998;8:1649–59.CrossRef

34.

University of Campinas (UNICAMP). Center for Studies and Research in Food. In: Brazilian Table of Food Composition, 4th ed. Sao Paulo: Campinas (2011).

35.

World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. In: Report of a WHO Consultation. WHO Technical Report Series no. 894. Geneva: WHO.

36.

World Health Organization (WHO). WHO Waist Circumference and Waist-Hip Ratio. Report of a WHO Expert Consultation. Geneva: World Health Organization; 2008. https://www.who.int/publications/i/item/9789241501491.

37.

Kyle UG, Bosaeus I, De-Lorenzo AD, Deurenberg P, Elia M, Manuel-Gómez J, Lilienthal-Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols A, Pichard C, ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430–53. https://doi.org/10.1016/j.clnu.2004.09.012.CrossRefPubMed

38.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. https://doi.org/10.1093/clinchem/18.6.499.CrossRefPubMed

39.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Turner RC Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9. https://doi.org/10.1007/BF00280883.CrossRefPubMed

40.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2012;3:1–150.

41.

Langewouters GJ, Settels JJ, Roelandt R, Wesseling KH. Why use Finapres or Portapres rather than intra-arterial or intermittent non-invasive techniques of blood pressure measurement? J Med Eng Technol. 1998;22(1):37–43.CrossRefPubMed

42.

Bos WJ, van Goudoever J, van Montfrans GA, van den Meiracker AH, Wesseling KH. Reconstruction of brachial artery pressure from noninvasive finger pressure measurements. Circulation. 1996;94(8):1870–5.CrossRefPubMed

43.

Brant LC, Barreto SM, Passos VM, Ribeiro AL. Reproducibility of peripheral arterial tonometry for the assessment of endothelial function in adults. J Hypertens. 2013;31:1984–1890. https://doi.org/10.1097/HJH.0b013e328362d913.CrossRefPubMed

44.

Roustit M, Millet C, Blaise S, Dufournet B, Cracowski JL. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res. 2010;80(3):505–11. https://doi.org/10.1016/j.mvr.2010.05.012.CrossRefPubMed

45.

Hellmann M, Roustit M, Cracowski JL. Skin microvascular endothelial function as a biomarker in cardiovascular diseases? Pharmacol Rep. 2015;67:803–10. https://doi.org/10.1016/j.pharep.2015.05.008.CrossRefPubMed

46.

Richardson JTE. Eta squared and partial eta squared as measures of effect size in educational research. Educ Res Rev. 2011;6(2):135–47. https://doi.org/10.1016/j.edurev.2010.12.001.CrossRef

47.

EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific opinion on the safety of caffeine. EFSA J. 2015;13(5):4102. https://doi.org/10.2903/j.efsa.2015.4102.CrossRef

48.

Mort JR, Kruse HR. Timing of blood pressure measurement related to caffeine consumption. Ann Pharmacother. 2008;42(1):105–10. https://doi.org/10.1345/aph.1K337.CrossRefPubMed

49.

Zimmermann-Viehoff F, Thayer J, Koenig J, Herrmann C, Weber CS, Deter HC. Short-term effects of espresso coffee on heart rate variability and blood pressure in habitual and non-habitual coffee consumers-a randomized crossover study. Nutr Neurosci. 2016;19(4):169–75. https://doi.org/10.1179/1476830515Y.0000000018.CrossRefPubMed

50.

Lovallo WR, Wilson MF, Vincent AS, Sung BH, McKey BS, Whitsett TL. Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension. 2004;43(4):760–5. https://doi.org/10.1161/01.HYP.0000120965.63962.93.CrossRefPubMed

51.

Farag NH, Vincent AS, Sung BH, Whitsett TL, Wilson MF, Lovallo WR. Caffeine tolerance is incomplete: persistent blood pressure responses in the ambulatory setting. Am J Hypertens. 2005;18(5 Pt 1):714–9. https://doi.org/10.1016/j.amjhyper.2005.03.738.CrossRefPubMed

52.

McMullen MK, Whitehouse JM, Shine G, Towell A. Habitual coffee and tea drinkers experienced increases in blood pressure after consuming low to moderate doses of caffeine; these increases were larger upright than in the supine posture. Food Funct. 2011;2(3–4):197–203. https://doi.org/10.1039/c0fo00166j.CrossRefPubMed

53.

Hu GL, Wang X, Zhang L, Qiu MH. The sources and mechanisms of bioactive ingredients in coffee. Food Funct. 2019;10(6):3113–26. https://doi.org/10.1039/c9fo00288j.CrossRefPubMed

54.

Higashi Y. Coffee and endothelial function: a coffee paradox? Nutrients. 2019;11(9):2104. https://doi.org/10.3390/nu11092104.CrossRefPubMedPubMedCentral

55.

Kajikawa M, Maruhashi T, Hidaka T, Nakano Y, Kurisu S, Matsumoto T, Iwamoto Y, Kishimoto S, Matsui S, Aibara Y, Yusoff FM, Kihara Y, Chayama K, Goto C, Noma K, Nakashima A, Watanabe T, Tone H, Hibi M, Osaki N, Katsuragi Y, Higashi Y. Coffee with a high content of chlorogenic acids and low content of hydroxyhydroquinone improves postprandial endothelial dysfunction in patients with borderline and stage 1 hypertension. Eur J Nutr. 2019;58(3):989–96. https://doi.org/10.1007/s00394-018-1611-7.CrossRefPubMed

56.

Sasaki H, Hirasawa A, Washio T, Ogoh S. Acute effect of coffee drinking on dynamic cerebral autoregulation. Eur J Appl Physiol. 2016;116(5):879–84. https://doi.org/10.1007/s00421-016-3345-7.CrossRefPubMed

57.

Dwan K, Li T, Altman DG, Elbourne D. CONSORT 2010 statement: extension to randomised crossover trials. BMJ. 2019;366:l4378. https://doi.org/10.1136/bmj.l4378.CrossRefPubMedPubMedCentral

58.

Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen. 2012;141(1):2–18. https://doi.org/10.1037/a0024338.CrossRefPubMed

59.

Sullivan GM, Feinn R. Using effect size-or why the P value is not enough. J Grad Med Educ. 2012;4(3):279–82. https://doi.org/10.4300/JGME-D-12-00156.1.CrossRefPubMedPubMedCentral

Titel: Acute Effects of Coffee Consumption on Blood Pressure and Endothelial Function in Individuals with Hypertension on Antihypertensive Drug Treatment: A Randomized Crossover Trial
verfasst von: Fernanda Barboza de Araujo Lima de Castro
Flávia Garcia Castro
Michelle Rabello da Cunha
Sidney Pacheco
Otniel Freitas-Silva
Mario Fritsch Neves
Marcia Regina Simas Torres Klein
Publikationsdatum: 03.02.2024
Verlag: Springer International Publishing
Erschienen in: High Blood Pressure & Cardiovascular Prevention / Ausgabe 1/2024
Print ISSN: 1120-9879
Elektronische ISSN: 1179-1985
DOI: https://doi.org/10.1007/s40292-024-00622-8

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Acute Effects of Coffee Consumption on Blood Pressure and Endothelial Function in Individuals with Hypertension on Antihypertensive Drug Treatment: A Randomized Crossover Trial

Abstract

Introduction

Aim

Methods

Results

Conclusion

Neu im Fachgebiet Kardiologie

Ist Fasten vor Koronarinterventionen wirklich nötig?

PET kann infarktgefährdete Koronararterien entdecken

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Kardiologie

Springer Medizin

Abstract

Introduction

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

A Mobile App-based Approach in Cardiovascular Disease Prevention: A Prospective Randomized Study

Acknowledgement to Referees

Comparison of vitamin K and non-vitamin K oral anticoagulants and the bleeding frequency in the emergency department

Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry

Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments

Neu im Fachgebiet Kardiologie

Ist Fasten vor Koronarinterventionen wirklich nötig?

PET kann infarktgefährdete Koronararterien entdecken

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Kardiologie